Table I.

Patient characteristics.

Age, years
Median	70
Range	29–89
Gender, no. (%)
Male	118 (75.2)
Female	39 (24.8)
Performance status, no. (%)
0	65 (41.4)
1	50 (31.8)
2	14 (8.9)
Unknown	28 (17.8)
Tumor stage, no. (%)
T1G3	27 (17.2)
T2	59 (37.6)
T3	61 (38.9)
T4	10 (6.4)
Tumor grade, no. (%)
2	28 (17.8)
3	128 (81.5)
Histopathology, no. (%)
Pure UC	145 (92.4)
UC with SCC	5 (3.2)
UC with adenocarcinoma	7 (4.5)
Total cisplatin dose, mg
Median	240
Range	30–406
Total radiation dose, Gy
Median	48.6
Range	18–63

UC, urothelial carcinoma; SCC, squamous cell carcinoma.